Shares of Diabetes-related Stocks Closed Lower Following Data From Lilly Showing Weekly Tirzepatide Injections Reduced the Risk of Progression to Type 2 Diabetes by 94% in Adults With Pre-diabetes and Obesity
糖尿病相关股票收盘下跌，此前Eli Lilly的数据显示，每周注射Tirzepatide可将患有糖尿病前期和肥胖症的成年人的2型糖尿病风险降低94％。